Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-arm phase II trial of 5-fluorouracil, folinic acid, and oxaliplatin in adenocarcinoma of unknown primary
KCT0000410Phase 2Recruiting
- Sponsor
- Korea Institute of Radiological & Medical Sciences
- Start
- Nov 2009
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil, folinic acid and oxaliplatin in Adenocarcinoma, sponsored by Korea Institute of Radiological & Medical Sciences. Started Nov 2009; status: recruiting.
02
Drugs
fluorouracilfolinic acidoxaliplatin
03
Conditions
Adenocarcinoma
Beyond the preview
Go deeper on KCT0000410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000410.